ArticleFrontiers in bioengineering and biotechnology2025
Plant-derived nanovesicles from
Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Endothelial dysfunction is increasingly recognized as an early and central event in the onset of cardiovascular and neurodegenerative diseases. Methods: PDNVs were isolated from Results: Ginkgo PDNV isolates comprise a heterogeneous population of nanometer sized particles, including vesicles with single and double layers. Proteomics revealed seed storage proteins (legumin and ginnacin) and membrane-associated ATPases, HSP90, catalase, phosphoenolpyruvate carboxylase (PEPC), and eEF1A. PDNVs were non-toxic up to 50 μg/mL; at 100 μg/mL, they enhanced mitochondrial activity but triggered early apoptosis and necrosis. PDNVs did not increase ROS production, even in the presence of H Conclusion: Ginkgo seed-derived PDNVs exhibit vascular-protective and anti-inflammatory properties, supporting their potential as safe, multifunctional agents for endothelial modulation. Further studies are warranted to explore their therapeutic applications in vascular biology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.